News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Santarus Inc. (SNTS) and VeroScience Announce CYCLOSET (bromocriptine mesylate) Data Presentations at the American Diabetes Association Meeting


6/21/2013 7:00:01 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Santarus, Inc. (NASDAQ: SNTS) and VeroScience, LLC today announced that clinical data on CYCLOSET® (bromocriptine mesylate) will be featured in two poster presentations at the 73rd Scientific Sessions of the American Diabetes Association being held at McCormick Place in Chicago, Ill. from June 21 – 25, 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES